Response to abatacept is associated with the inhibition of proteasome β1i expression in T cells of patients with rheumatoid arthritis | RMD Open
PPT - Abatacept (hCTLA4-Ig) For the Treatment of Rheumatoid Arthritis: PowerPoint Presentation - ID:286368
Strategies toward rheumatoid arthritis therapy; the old and the new - Abbasi - 2019 - Journal of Cellular Physiology - Wiley Online Library
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Abatacept Mechanism of Action: Concordance With Its Clinical Profile | Reumatología Clínica
Abatacept Mechanism of Action: Concordance With Its Clinical Profile - ScienceDirect
Drugs used in treatment of rheumatoid arthiritis
Abatacept - Renal Fellow Network
Potential of regulatory T-cell-based therapies in the management of severe COVID-19 | European Respiratory Society
Cytokines And Biologic Treatment in Arthritis - ppt download
Biologics in Rheumatology - презентация онлайн
Treat to Target, Role of Orencia in Achieving the target. - ppt download
Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis - Value in Health
illustration describing the mechanism of action of abatacept. Abatacept... | Download Scientific Diagram
Mechanism of action of abatacept. Under normal circumstances, CD80/86... | Download Scientific Diagram
Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study | RMD Open
Current immunotherapy in rheumatoid arthritis | Immunotherapy
Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study - The Lancet Rheumatology
References in Are calcineurin inhibitors-free regimens ready for prime time? - Kidney International
Costimulation blockade in autoimmunity and transplantation - Journal of Allergy and Clinical Immunology
Abatacept (hCTLA4-Ig) For the Treatment of Rheumatoid Arthritis: Product Attributes and Mechanism of Action Joy Williams, Ph.D. Arthritis Advisory Committee. - ppt download
Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance | The Journal of Immunology
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study | The Journal of Rheumatology
Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs | The Journal of Rheumatology
Drug Insight: abatacept for the treatment of rheumatoid arthritis | Nature Reviews Rheumatology
Abatacept, a Novel CD80/86–CD28 T Cell Co‐stimulation Modulator, in the Treatment of Rheumatoid Arthritis - Korhonen - 2009 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
